This episode brings pharmacology into the breathing lung—an organ that must stay open to the world while remaining exquisitely controlled. We explore how airway tone, mucus production, inflammation, and immune signalling are regulated, and why asthma and COPD represent different failures of that balance. Rather than treating the lung as a passive tube, this episode frames it as an actively governed interface—one that drugs must negotiate carefully to restore flow without provoking harm.

Key takeaways you’ll carry forward:

* Airway tone and reactivity: how smooth muscle, nerves, and mediators determine resistance.

* Inflammation versus obstruction: why asthma and COPD diverge mechanistically despite shared symptoms.

* Bronchodilators in context: β₂-agonists and antimuscarinics as tools for airflow, not cures.

* Anti-inflammatory strategy: corticosteroids as long-game regulators rather than rescue agents.

* Matching drug to disease logic: why mechanism matters more than symptom relief alone.

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe